2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Pancreatic Ductal
1
Anophthalmia with pulmonary hypoplasia
1
Interventions
Gemcitabine
15
130-nm albumin-bound paclitaxel
10
Albumin-Bound Paclitaxel
7
Oxaliplatin
5
Paclitaxel
4
Leucovorin
4
Fluorouracil
4
Carboplatin
4
Cisplatin
3
Cetuximab
3
Bevacizumab
3
pembrolizumab
2
napabucasin
2
Pemetrexed
2
PEGPH20
2
MK-4721
2
Irinotecan
2
tremelimumab
1
selinexor
1
relacorilant
1
ponatinib
1
neratinib
1
irinotecan sucrosofate
1
folfirinox
1
ensituximab
1
durvalumab
1
contrast agent BR1
1
cobimetinib
1
ceritinib
1
cc-486
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Pancreatic Ductal
×
Long Interspersed Nucleotide Elements
×
Clear all
NCT05475366
2026-05-01
PACsign
Institut Curie
Phase NA
Recruiting
85 enrolled